Timing of multikinase inhibitor initiation in differentiated thyroid cancer
Sign Up to like & getrecommendations! Published in 2017 at "Endocrine-Related Cancer"
DOI: 10.1530/erc-17-0016
Abstract: There are limited treatment options for patients with radioactive iodine refractory, progressive differentiated thyroid cancer. Although there is consensus that multikinase inhibitor therapy should be considered in patients with progressive disease with considerable tumor load… read more here.
Keywords: multikinase; differentiated thyroid; thyroid cancer; cancer ... See more keywords